Josee Perreault
Overview
Explore the profile of Josee Perreault including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
596
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Leiva-Torres G, Cigna M, Constanzo-Yanez J, St-Louis M, Perreault J, Lavoie J, et al.
Transfusion
. 2024 Mar;
64(4):716-726.
PMID: 38497419
Background: Red blood cell transfusion is an effective treatment for patients with sickle cell disease (SCD). Alloimmunization can occur after a single transfusion, limiting further usage of blood transfusion. It...
2.
Tauzin A, Beaudoin-Bussieres G, Benlarbi M, Nayrac M, Bo Y, Gendron-Lepage G, et al.
Viruses
. 2023 Sep;
15(9).
PMID: 37766332
While an important part of the world's population is vaccinated against SARS-CoV-2, new variants continue to emerge. We observe that even after a fifth dose of the mRNA bivalent vaccine,...
3.
Beaudoin-Bussieres G, Tauzin A, Dionne K, Gendron-Lepage G, Medjahed H, Perreault J, et al.
Viruses
. 2023 Jun;
15(6).
PMID: 37376574
Since the beginning of the SARS-CoV-2 pandemic, several variants of concern (VOCs), such as the Alpha, Beta, Gamma, Delta and Omicron variants, have arisen and spread worldwide. Today, the predominant...
4.
Bazin R, Rochette S, Perreault J, Fournier M, Gregoire Y, Boivin A, et al.
Infect Dis (Lond)
. 2023 Apr;
55(6):425-430.
PMID: 37039629
Background: Serosurveys have been key to public health decision-making since the beginning of the SARS-CoV-2 pandemic. However, several studies have uncovered that vaccination blunts the anti-nucleocapsid (N) response to a...
5.
Tauzin A, Benlarbi M, Medjahed H, Gregoire Y, Perreault J, Gendron-Lepage G, et al.
Vaccines (Basel)
. 2023 Feb;
11(2).
PMID: 36851122
The Omicron BQ.1.1 variant is now the major SARS-CoV-2 circulating strain in many countries. Because of the many mutations present in its Spike glycoprotein, this variant is resistant to humoral...
6.
Lemieux W, Perreault J, Leiva-Torres G, Baillargeon N, Yanez J, Chevrier M, et al.
Future Virol
. 2023 Feb;
PMID: 36844192
More data is required regarding the association between HLA allele and red blood cell (RBC) antigen expression in regard to SARS-CoV-2 infection and COVID-19 susceptibility. ABO, RhD, 37 other RBC...
7.
Germain M, Lewin A, Bazin R, Dieude M, Perreault J, Boivin A, et al.
BMJ Open
. 2023 Feb;
13(2):e068803.
PMID: 36822809
Purpose: The long-term humoral immunity to COVID-19 is not well understood owing to the continuous emergence of new variants of concern, the evolving vaccine-induced and infection-induced immunity, and the limited...
8.
Tauzin A, Nicolas A, Ding S, Benlarbi M, Medjahed H, Chatterjee D, et al.
Cell Rep
. 2023 Jan;
42(1):111998.
PMID: 36656710
Several severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron subvariants have recently emerged, becoming the dominant circulating strains in many countries. These variants contain a large number of mutations in...
9.
Laumaea A, Lewin A, Chatterjee D, Marchitto L, Ding S, Gendron-Lepage G, et al.
Transfusion
. 2022 Aug;
62(9):1779-1790.
PMID: 35919021
Background: Plateletpheresis involves platelet separation and collection from whole blood while other blood cells are returned to the donor. Because platelets are replaced faster than red blood cells, as many...
10.
Lewin A, De Serres G, Gregoire Y, Perreault J, Drouin M, Fournier M, et al.
Can J Public Health
. 2022 Apr;
113(3):385-393.
PMID: 35380364
Objectives: We previously estimated the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies following the first pandemic wave at 2.23% in Québec, Canada. Following the much bigger second...